Editas Medicine, Inc. (EDIT) Cash Flow Statement
Editas Medicine, Inc. (EDIT) generated -$119.9M of operating cash flow over the twelve months to 2026-06-30, spent $691000 on capital expenditure and had free cash flow of -$120.5M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
EDITEditas Medicine, Inc.Follow EDIT — free
—
Price chart with a free account
- Market cap
- 368.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -45.7 | -40.7 | -179.8 | -163.8 | -177.3 | -132.2 | -210.3 | -165.2 | -119.9 | |
| Capital expenditure | 4.8 | 6.2 | 7.2 | 8.0 | 4.1 | 4.7 | 8.8 | 0.6 | -0.7 | |
| Free cash flow | -50.5 | -46.8 | -187.0 | -171.8 | -181.5 | -136.9 | -219.1 | -165.8 | -120.6 | |
| Stock-based compensation | 26.6 | 27.2 | 23.2 | 43.4 | 29.3 | 19.8 | 21.4 | 10.0 | — |
USD millions · SEC XBRL
Editas Medicine, Inc. — questions
- What is Editas Medicine, Inc.'s operating cash flow?
- -$119.9M over the twelve months to 2026-06-30.
- How much does Editas Medicine, Inc. spend on capital expenditure?
- $691000 over the twelve months to 2026-06-30.
- What is Editas Medicine, Inc.'s free cash flow?
- -$120.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Editas Medicine, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.